Tag: Wegener’s

Rituximab noninferior to conventional therapy in ANCA-associated vasculitis: RAVE Trial

byAkira Shishido

February 14, 2014

Image: PD/Rituximab (Rituxan, MabThera) 1. At 18 months, patients with ANCA-associated vasculitis treated with one course of rituximab had similar ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Middle meningeal artery embolization reduces adverse events in patients with subdural hematomas
Semaglutide reduces body weight and pain symptoms in obese patients with knee osteoarthritis
Late-arresting attenuated parasite provides greater malaria protection than early-arresting parasite

No Result

View All Result